HOOKIPA Pharma, Inc. - HOOK Book Capitalization

HOOKIPA Pharma Inc. (HOOK) is creating an advanced immunotherapy environment by leveraging arenavirus technologies to combat infections and oncology. The company aims for global leadership through partnerships with major corporations and the expansion of clinical trials. Processes have been optimized via data analysis automation and robotic molecule screening. The current metric stands at 0.03. The visualization of the asset's market price is presented below.

HOOKIPA Pharma Inc. maintains its position in the biotech sector by investing in the environmental modernization of laboratories and emission filtration systems. An analysis of the company's capitalization based on the balance sheet reflects the value of net assets minus liabilities, which serves as a more stable indicator of fundamental value than volatile quotes during periods of market consolidation, confirming the long-term resilience of the business.